Johan Törlén

About me
Publications
CV
Public outreach and news

About me

Affiliated researcher at KI (PhD 2019) and MD, board specialist in
hematology and senior registrar at the Cell therapy and Allogeneic Stem Cell Transplantation unit
(CAST) at Karolinska University Hospital

Articles

Article: TRANSPLANTATION AND CELLULAR THERAPY. 2023;29(6):376.e1-376.e11

Effect of mTOR Inhibition with Sirolimus on Natural Killer Cell Reconstitution in Allogeneic Stem Cell Transplantation.

Haroun-Izquierdo A; Lanuza PM; Pfefferle A; Netskar H; Ask EH; Törlén J; Björklund A; Sohlberg E; Malmberg K-J
Article: FRONTIERS IN IMMUNOLOGY. 2022;13:954716

T cell receptor excision circles are potential predictors of survival in adult allogeneic hematopoietic stem cell transplantation recipients with acute myeloid leukemia.

Söderström A; Vonlanthen S; Jönsson-Videsäter K; Mielke S; Lindahl H; Törlén J; Uhlin M
Article: ORAL DISEASES. 2021;27(5):1217-1225

Oral mucositis after tacrolimus/sirolimus or cyclosporine/methotrexate as graft-versus-host disease prophylaxis.

Garming Legert K; Ringdén O; Remberger M; Törlén J; Mattsson J; Dahllöf G
Article: INTERNATIONAL JOURNAL OF HEMATOLOGY. 2021;113(5):712-722

Cytokine levels following allogeneic hematopoietic cell transplantation: a match-pair analysis of home care versus hospital care.

Ringdén O; Remberger M; Törlén J; Finnbogadottir S; Svahn B-M; Sadeghi B
Article: CTS-CLINICAL AND TRANSLATIONAL SCIENCE. 2020;13(2):293-300

Reduced Risk of Sinusoidal Obstruction Syndrome of the Liver after Busulfan-Cyclophosphamide Conditioning Prior to Allogeneic Hematopoietic Stem Cell Transplantation.

El-Serafi I; Remberger M; Ringdèn O; Törlén J; Sundin M; Björklund A; Winiarski J; Mattsson J
Article: TRANSPLANTATION AND CELLULAR THERAPY. 2019;25(6):1260-1268

Effect of Graft-versus-Host Disease Prophylaxis Regimens on T and B Cell Reconstitution after Allogeneic Hematopoietic Stem Cell Transplantation.

Törlén J; Gaballa A; Remberger M; Mörk L-M; Sundberg B; Mattsson J; Uhlin M
Article: FRONTIERS IN IMMUNOLOGY. 2019;10:189

Individualization of Hematopoietic Stem Cell Transplantation Using Alpha/Beta T-Cell Depletion.

Rådestad E; Sundin M; Törlén J; Thunberg S; Önfelt B; Ljungman P; Watz E; Mattsson J; Uhlin M
Article: INTERNATIONAL JOURNAL OF HEMATOLOGY. 2017;106(4):471-475

Toxicological effects of fludarabine and treosulfan conditioning before allogeneic stem-cell transplantation.

Remberger M; Törlen J; Serafi IE; Garming-Legert K; Björklund A; Ljungman P; Sundin M; Hassan M; Mattsson J
Article: TRANSPLANTATION AND CELLULAR THERAPY. 2017;23(4):677-683

Impact of Pretransplantation Indices in Hematopoietic Stem Cell Transplantation: Knowledge of Center-Specific Outcome Data Is Pivotal before Making Index-Based Decisions.

Törlén J; Remberger M; Le Blanc K; Ljungman P; Mattsson J
Article: FRONTIERS IN IMMUNOLOGY. 2017;8:717

Combining Flow and Mass Cytometry in the Search for Biomarkers in Chronic Graft-versus-Host Disease.

Stikvoort A; Chen Y; Rådestad E; Törlén J; Lakshmikanth T; Björklund A; Mikes J; Achour A; Gertow J; Sundberg B; Remberger M; Sundin M; Mattsson J; Brodin P; Uhlin M
Article: HAEMATOLOGICA. 2016;101(11):1417-1425

A prospective randomized trial comparing cyclosporine/methotrexate and tacrolimus/sirolimus as graft-versus-host disease prophylaxis after allogeneic hematopoietic stem cell transplantation.

Törlén J; Ringdén O; Garming-Legert K; Ljungman P; Winiarski J; Remes K; Itälä-Remes M; Remberger M; Mattsson J
Article: TRANSPLANTATION AND CELLULAR THERAPY. 2016;22(9):1684-1689

Risk Factors for Invasive Mold Infections and Implications for Choice of Prophylaxis after Allogeneic Stem Cell Transplantation.

Blennow O; Remberger M; Törlén J; Szakos A; Ljungman P; Mattsson J
Article: TRANSPLANT INFECTIOUS DISEASE. 2015;17(6):785-794

Prolonged outbreak of adenovirus A31 in allogeneic stem cell transplant recipients.

Swartling L; Allard A; Törlen J; Ljungman P; Mattsson J; Sparrelid E
Article: TRANSPLANTATION AND CELLULAR THERAPY. 2015;21(5):889-893

Effect of Total Nucleated and CD34(+) Cell Dose on Outcome after Allogeneic Hematopoietic Stem Cell Transplantation.

Remberger M; Törlén J; Ringdén O; Engström M; Watz E; Uhlin M; Mattsson J
Article: TRANSPLANTATION AND CELLULAR THERAPY. 2014;20(9):1418-1425

Low CD34 dose is associated with poor survival after reduced-intensity conditioning allogeneic transplantation for acute myeloid leukemia and myelodysplastic syndrome.

Törlén J; Ringdén O; Le Rademacher J; Batiwalla M; Chen J; Erkers T; Ho V; Kebriaei P; Keever-Taylor C; Kindwall-Keller T; Lazarus HM; Laughlin MJ; Lill M; O'Brien T; Perales M-A; Rocha V; Savani BN; Szwajcer D; Valcarcel D; Eapen M
Article: PEDIATRIC TRANSPLANTATION. 2014;18(4):398-404

Home care during neutropenia after allogeneic hematopoietic stem cell transplantation in children and adolescents is safe and may be more advantageous than isolation in hospital.

Ringdén O; Remberger M; Törlén J; Engström M; Fjaertoft G; Mattsson J; Svahn B-M

All other publications

Review: SUPPORTIVE CARE IN CANCER. 2023;31(12):702

Incidence, severity, and temporal development of oral complications in pediatric allogeneic hematopoietic stem cell transplant patients - a multicenter study.

Agholme MB; Dahllöf G; Törlén JK; Majorana A; Brennan MT; von Bültzingslöwen I; Tan PL; Hu S; Sim YF; Hong C
Editorial comment: CLINICAL PHARMACOLOGY & THERAPEUTICS. 2020;107(2):308

Protocol Changes Lead to Lowering of SOS Rates
Conference publication: BONE MARROW TRANSPLANTATION. 2020;55(SUPPL 1):336

Cytokine Levels following Allogeneic Hematopoietic Stem Cells Transplantation. A match-pair Analysis of Home Care Versus Hospital Care

Ringden O; Remberger M; Torlen J; Finnbogadottir S; Svahn B-M; Sadeghi B
KI thesis / dissertation: 2019

From risk indices to reconstitution of immunity : studies of outcome-related factors in patients undergoing allogeneic hematopoietic stem cell transplantation

Karlsson Törlén, Johan
Conference publication: BONE MARROW TRANSPLANTATION. 2017;52:S338-S339

Toxicological side effects of fludarabin and treosulfan conditioning before allogeneic stem-cell transplantation

Mattsson J; Torlen J; El Serafi I; Legert KG; Bjorklund A; Ljungman P; Sundin M; Hassan M; Remberger M
Conference publication: SCANDINAVIAN JOURNAL OF IMMUNOLOGY. 2017;86(4):264

Identifying cellular subsets diagnostic for severity chronic GVHD

Stikvoort A; Chen Y; Radestad E; Karlsson-Torlen J; Tadepally L; Bjorklund A; Mikes J; Achour A; Gertow J; Sundberg B; Remberger M; Sundin M; Mattsson J; Brodin P; Uhlin M
Meeting abstract: TRANSPLANTATION AND CELLULAR THERAPY. 2016;22(3):s415

Identifying Cellular Subsets Diagnostic for Severity and Organ Specific Chronic GVHD

Stikvoort A; Rodestad E; Gertow J; Torlen J; Sundin M; Mattsson J; Uhlin M
Conference publication: BONE MARROW TRANSPLANTATION. 2016;51:S21

A prospective randomized study comparing tacrolimus and sirolimus versus cyclosporine and methotrexate as gvhd prophylaxis in allogeneic hematopoietic stem cell transplantation

Torlen J; Ringden O; Garming-Legert K; Ljungman P; Winiarski J; Remes K; Itala-Remes M; Remberger M; Mattsson J
Conference publication: EUROPEAN JOURNAL OF IMMUNOLOGY. 2016;46:844

Identifying cellular subsets diagnostic for severity and organ specificity chronic GVHD

Stikvoort A; Chen Y; Radestad E; Torlen J; Sundberg B; Sundin M; Mattsson J; Brodin P; Uhlin M
Meeting abstract: TRANSPLANTATION AND CELLULAR THERAPY. 2015;21(2):s351

An Increasing Severity of Chronic GvHD Is Associated to an Activated and Cytotoxic T Cell Mediated Immune-Phenotype

Stikvoort A; Radestad E; Torlen J; Mattsson J; Uhlin M
Conference publication: BONE MARROW TRANSPLANTATION. 2015;50:S77

Prolonged Outbreak of Adenovirus A31 Among Allogeneic Stem Cell Transplant Recipients

Swartling LP; Allard A; Torlen J; Ljungman P; Mattsson J; Sparrelid E

Employments

Affiliated to Research, Department of Medicine, Huddinge, Karolinska Institutet, 2024-2025
Affiliated to Research, Department of Clinical Science, Intervention and Technology, Karolinska Institutet, 2022-2025

Degrees and Education

Degree Of Doctor Of Philosophy, Department of Oncology-Pathology, Karolinska Institutet, 2019
University Medical Degree, Karolinska Institutet, 2008

About me

Articles

All other publications

Employments

Degrees and Education

News from KI

Events from KI